December 9, 2014
Save the Date for Dancing on the Valentine: A Redux – A Fundraiser for the Leukemia & Lymphoma Society
Seattle, WA – Dancing on the Valentine, an annual music benefit for the Leukemia and Lymphoma Society has raised over $40,000 since its debut in 2004. DOTV celebrates its 10th anniversary on Friday, February 13th, 2015 at Neumos, located at 925 E Pike Street. To commemorate the benefit’s tenth year, local musicians including Katie Kate, Thunderpussy, Gibraltar, The Swearengens & Jupe Jupe will celebrate the music of the many bands that have been featured at DOTV over the years: Joy Division, New Order, David Bowie, Depeche Mode, The Cure, Madonna, and of course, Duran Duran. The event will include raffle prizes from local businesses, as well as a free photo booth by the talented Ben Haley.
Producer Jenny George was diagnosed with leukemia at age 12, given less than thirty days to live, and told that she would never have children. Jenny beat the odds. Today she is a dedicated mother and an advocate for cancer research and treatment. In addition to hosting the annual Benefit, she has donated her DNA to help scientists understand, diagnose, and treat leukemia and lymphoma.
Dancing on the Valentine has raised more than $40,000 for Leukemia research over the years and Jenny hopes to add another $10,000 to that figure in 2015.
This year features performances by Evening Bell, Exohxo, Gibraltar, Sam Ford of Goodbye Heart, Jupe Jupe, Katie Kate, Lazer Kitty, Strong Suit, The Service Providers, The Swearengens, 3rd Base (featuring Jenny’s son, Atticus), Thunderpussy, Trick Candles, and more!
DJ: Mike Steves
Emcee: Dana from Three Imaginary Girls
Ticket Link: http://goo.gl/wFphi0
Dancing on the Valentine is an annual benefit concert to raise money for the Leukemia & Lymphoma Society, the world’s largest voluntary health organization dedicated to funding blood cancer research, education, and patient services. All proceeds go to the Society, whose mission is to cure leukemia, lymphoma, Hodgkin’s disease, and myeloma, as well as improve the quality of life of patients and their families.